Changes in circulating microRNA levels associated with prostate cancer.

Abstract

These observations suggest that changes in miR concentration in prostate cancer patients may be identified by analysing various body fluids. Moreover, circulating miRs may be used to diagnose and stage prostate cancer.

Full Text

DOI - British journal of cancer (DOI)
Swets Information Services - full-text online
Nature Publishing Group - full-text online
EBSCO - full-text online

Subjects

Similar articles

Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer. (2008-05-12)
Vitamin D(3) supplementation, low-risk prostate cancer, and health disparities. (2012-12-07)
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. (2009-03-02)
Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. (2012-08-10)
Variations in circulating sex steroid levels in metastatic prostate cancer patients with combined androgen blockade: observation and implication. (2013-03-28)
The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. (2012-10-23)
Endocrine control and physiology of the prostate. (2004-12-28)
Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. (2012-12-27)
Role of Androgen and Vitamin D Receptors in Endothelial Cells from Benign and Malignant Human Prostate. (2013-04-02)

Authors

Publication date

2012-02-15

Journal

British journal of cancer
Br J Cancer (1532-1827)

Journal topics

Language

Eng.

Copyright

British journal of cancer

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

Release reference

Br J Cancer. 2012 Feb;106(4):768-74

Related books

Español | English

© Galenicom 1999-2013